Loading…

Effect of combined goniotomy and phacoemulsification on intraocular pressure in open‐angle glaucoma patients

Importance Although goniotomy is known to be successful in treating congenital glaucoma, its effect in adult glaucoma patients remains unclear. Background To evaluate the efficacy and safety of goniotomy performed simultaneously with cataract surgery in treatment of open‐angle glaucoma (OAG). Design...

Full description

Saved in:
Bibliographic Details
Published in:Clinical & experimental ophthalmology 2019-08, Vol.47 (6), p.757-765
Main Authors: Kim, Woo‐Jin, Kim, Ju‐Mi, Lee, Woo‐Hyuk, Kim, Kyoung Nam, Kim, Chang‐sik
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Importance Although goniotomy is known to be successful in treating congenital glaucoma, its effect in adult glaucoma patients remains unclear. Background To evaluate the efficacy and safety of goniotomy performed simultaneously with cataract surgery in treatment of open‐angle glaucoma (OAG). Design Retrospective comparative study. Participants A total of 76 patients with moderately controlled OAG (intraocular pressure [IOP] ≤ 21 mmHg using medications) undergoing cataract surgery. Methods Comparison of patients who underwent the conventional goniotomy during cataract surgery (combined goniotomy group) with those who underwent cataract surgery alone (phaco group). Main Outcome Measures Changes in IOP and medications, and complications through 12 months. Results Baseline IOP was 18.2 ± 2.4 mmHg in the combined goniotomy group and 17.4 ± 1.9 mmHg in the phaco group; number of medications was 2.6 ± 1.1 and 2.4 ± 0.9, respectively (P > 0.05). The reduction in IOP and medication use from baseline in the combined goniotomy group was significantly greater at 12 months compared to the phaco group (−3.1 ± 2.9 mmHg vs −1.3 ± 2.4 mmHg and −1.2 ± 0.9 vs −0.7 ± 0.9, respectively, both P 
ISSN:1442-6404
1442-9071
DOI:10.1111/ceo.13506